TAIPY Projected Dividend Yield
ADR/Taisho Pharmaceutical Holdings Co Ltd ( OTCBB : TAIPY )Taisho Pharmaceutical Holdings is holding company engaged in the manufacture and sale of prescription drugs and over-the-counter drugs. Self-Medication segment is engaged in the manufacture and sale of OTC drugs, dietary supplements, healthcare products, personal care products and beverages. Co.'s principal products include "Pabron" (cold remedies), "Lipovitan" (energy drinks) and "RiUP" (hair regrowth treatments). Prescription Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs in the fields of infectious diseases, inflammatory/immunologic diseases, orthopedic disorders, central nervous system and metabolic diseases. 16 YEAR PERFORMANCE RESULTS |
TAIPY Dividend History Detail TAIPY Dividend News TAIPY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2023 |
N/A |
N/A |
Sep 29, 2023 |
Dec 18, 2023 |
0.0851 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jul 17, 2023 |
0.0865 |
2023 Total: |
0.1715 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 19, 2022 |
0.0916 |
2022 |
N/A |
N/A |
Mar 30, 2022 |
Jul 15, 2022 |
0.0918 |
2022 Total: |
0.1835 |
||||
2021 |
N/A |
N/A |
Sep 29, 2021 |
Dec 17, 2021 |
0.1100 |
2021 |
N/A |
N/A |
Mar 30, 2021 |
Jul 15, 2021 |
0.1125 |
2021 Total: |
0.2226 |
||||
2020 |
N/A |
N/A |
Sep 29, 2020 |
Dec 17, 2020 |
0.1202 |
2020 |
N/A |
N/A |
Mar 30, 2020 |
Jul 14, 2020 |
0.1390 |
2020 Total: |
0.2593 |
||||
2019 |
N/A |
N/A |
Sep 30, 2019 |
Dec 18, 2019 |
0.1148 |
2019 |
N/A |
N/A |
Mar 29, 2019 |
Jul 16, 2019 |
0.1622 |
2019 Total: |
0.2770 |